• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1550350-08
Device Problems Difficult to Remove (1528); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problem Vessel Or Plaque, Device Embedded In (1204)
Event Date 09/18/2019
Event Type  Injury  
Manufacturer Narrative
Exemption number (b)(4).The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The other additional 3 xience stents referenced are being filed under separate medwatch report numbers.
 
Event Description
It was reported that the procedure was to treat restenosis of 3 xience stents that were implanted in (b)(6) 2018.The stents were located in the left anterior descending (lad), circumflex and left main coronary arteries.The patient was symptomatic on (b)(6) 2019, with chest tightness and shortness of breath.An angiography was done to confirm restenosis and intervention was performed today, (b)(6) 2019.The 3.50x8 mm xience sierra was advanced with resistance noted with the previously implanted stents and once it was located in the proximal circumflex coronary artery it became stuck on one of the stents and could not be advanced or withdrawn.Finally the stent delivery system (sds) was able to be removed; however, the stent was not located on the sds when it came out of the anatomy.It was confirmed that the stent remained in the left main coronary artery and balloon angioplasty was used to crush the stent to the vessel.The patient remains hospitalized with a heart pump.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure as it is likely the device interacted with the previously implanted stents causing the reported failure to advance.During removal the device interacted with the previously implanted stents causing the reported difficulty to remove and subsequent stent dislodgement.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9182917
MDR Text Key163050045
Report Number2024168-2019-12479
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227394
UDI-Public08717648227394
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number1550350-08
Device Lot Number9062541
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/18/2019
Initial Date FDA Received10/11/2019
Supplement Dates Manufacturer Received11/15/2019
Supplement Dates FDA Received12/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
3 UNKNOWN XIENCE STENTS
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
-
-